Inspire Medical Systems, Inc. to Report Second Quarter 2024 Financial Results on August 6, 2024

Rhea-AI Summary

Inspire Medical Systems (NYSE: INSP) announced it will release its second quarter 2024 financial results on August 6, 2024, after market close. Following the release, the management team will host a conference call at 5:00 p.m. Eastern Time to discuss results and recent business developments. The webcast will be accessible via Inspire's Investor Relations page. Questions for management can be submitted through a provided registration link, which will generate a unique access code for the live call. A replay of the call will be available approximately two hours after the event and will remain accessible for two weeks on the company's website.

Positive

• Upcoming financial results release potentially brings positive business updates.
• Access to the conference call and replay enhances transparency and investor relations.

Negative

• None.

MINNEAPOLIS, July 02, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the second quarter 2024 after the close of trading on Tuesday, August 6. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.

A webcast of the call will be accessible via the Investor Relations page of the Inspire website or through this link: Inspire's Q2 2024 earnings call webcast. For those not planning to ask a question of management, the Company recommends listening via the webcast.

If you plan to ask a question, please use the following link: Inspire's Q2 2024 earnings call. After registering, an email will be sent, including dial-in details and a unique conference call access code required to join the live call. To ensure you are connected prior to the beginning of the call, the Company suggests registering a minimum of 10 minutes before the start of the call. 

Following the call, a replay will be available on the Company's Investor Relations website approximately two hours after the event and archived on the site for two weeks.

About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit www.inspiresleep.com.

Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
ezgiyagci@inspiresleep.com
617-549-2443

FAQ

When will Inspire Medical Systems report Q2 2024 financial results?

Inspire Medical Systems will report Q2 2024 financial results on August 6, 2024, after the market close.

How can I access the Inspire Medical Systems Q2 2024 earnings call?

The webcast of the Q2 2024 earnings call will be available via Inspire's Investor Relations page or through a provided link.

What time is the Inspire Medical Systems Q2 2024 earnings conference call?

The conference call will begin at 5:00 p.m. Eastern Time on August 6, 2024.

How can I submit questions for the Inspire Medical Systems Q2 2024 earnings call?

Questions can be submitted by registering through a provided link, which will generate a unique access code for the live call.

Will there be a replay available for the Inspire Medical Systems Q2 2024 earnings call?

Yes, a replay will be available approximately two hours after the event and will be archived on Inspire's Investor Relations website for two weeks.